{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:22:05Z","timestamp":1750537325903},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2018,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A 52-year-old woman diagnosed with mycosis fungoides was referred for <jats:sup>18<\/jats:sup>F-FDG PET\/CT before treatment for the evaluation of disease severity. The patient also underwent <jats:sup>68<\/jats:sup>Ga-pentixafor PET\/CT for further evaluation. FDG uptake was observed in cervical, axillary, and pelvic lymph nodes and multiple widespread skin lesions throughout the body, suggestive of extensive involvement of mycosis fungoides. All lesions were visually identifiable with high target-to-background ratio on <jats:sup>68<\/jats:sup>Ga-pentixafor PET\/CT which demonstrated marked CXCR4 expression in all lesions that were detected using <jats:sup>18<\/jats:sup>F-FDG PET\/CT.<\/jats:p>","DOI":"10.1097\/rlu.0000000000002166","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T17:55:24Z","timestamp":1529430924000},"page":"606-608","source":"Crossref","is-referenced-by-count":11,"title":["Imaging of Chemokine Receptor CXCR4 in Mycosis Fungoides Using 68Ga-Pentixafor PET\/CT"],"prefix":"10.1097","volume":"43","author":[{"given":"Serkan","family":"Kuyumcu","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, Istanbul Medical Faculty, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebru","family":"Yilmaz","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Istanbul Medical Faculty, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fikret","family":"B\u00fcy\u00fckkaya","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, Istanbul University, Istanbul, Turkey."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeynep G\u00f6zde","family":"\u00d6zkan","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Istanbul Medical Faculty, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seher Nilg\u00fcn","family":"\u00dcnal","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Istanbul Medical Faculty, and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20230925","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.2967\/jnumed.111.098798","article-title":"PET of CXCR4 expression by a (68)Ga-labeled highly specific targeted contrast agent","volume":"52","year":"2011","journal-title":"J Nucl Med"},{"key":"bib2-20230925","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1002\/cmdc.201100320","article-title":"PET imaging of CXCR4 receptors in cancer by a new optimized ligand","volume":"6","year":"2011","journal-title":"ChemMedChem"},{"key":"bib3-20230925","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejca.2012.05.005","article-title":"A review on CXCR4\/CXCL12 axis in oncology: no place to hide","volume":"49","year":"2013","journal-title":"Eur J Cancer"},{"key":"bib4-20230925","first-page":"410","article-title":"Biodistribution and radiation dosimetry for the chemokine receptor CXCR4-targeting probe 68Ga-pentixafor","volume":"3","year":"2015","journal-title":"J Nucl Med"},{"key":"bib5-20230925","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/bjd.13054","article-title":"Expression dynamics of CXCL12 and CXCR4 during the progression of mycosis fungoides","volume":"171","year":"2014","journal-title":"Br J Dermatol"},{"key":"bib6-20230925","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/RLU.0000000000002067","article-title":"Multiple myeloma presenting as a superscan on 68Ga-pentixafor PET\/CT","volume":"43","year":"2018","journal-title":"Clin Nucl Med"},{"key":"bib7-20230925","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2967\/jnumed.115.167361","article-title":"First-in-human experience of CXCR4-directed endoradiotherapy with 177Lu- and 90Y-labeled pentixather in advanced-stage multiple myeloma with extensive intra- and extramedullary disease","volume":"57","year":"2016","journal-title":"J Nucl Med"},{"key":"bib8-20230925","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ymeth.2017.09.002","article-title":"Chemokine receptor\u2014directed imaging and therapy","volume":"130","year":"2017","journal-title":"Methods"},{"key":"bib9-20230925","doi-asserted-by":"crossref","first-page":"77S","DOI":"10.2967\/jnumed.116.186874","article-title":"CXCR4 ligands: the next big hit?","volume":"58","year":"2017","journal-title":"Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003072-201808000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T05:06:26Z","timestamp":1695618386000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201808000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":9,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000002166","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]}}}